Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA grants fast track designation to Neopharm's NPL-2008 in autism disorder

April 14, 2008

In vivo cognitive enhancement by WAY-101, a novel 5-HT6 antagonist

April 14, 2008

Pfizer's novel 5-HT1B inverse agonist shows antidepressant activity in vivo

April 14, 2008

Futura Medical updates progress on development of TPR-100 using DermaSys

April 14, 2008

New preclinical data demonstrate antidepressant activity of ITI-007

April 14, 2008

BGC-20-0166 shows potential for obstructive sleep apnea

April 11, 2008

Novel CGRP antagonist profiled at Merck & Co.

April 11, 2008

Nebicapone increases levodopa exposure in Parkinson's disease patients

April 11, 2008

Wex commences phase III Tectin trial for cancer pain

April 10, 2008

Arena initiates screening in phase IIb clinical trial of APD-125 in primary insomnia

April 10, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...